GURIZZAN, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 420
EU - Europa 287
AS - Asia 194
AF - Africa 6
OC - Oceania 2
SA - Sud America 1
Totale 910
Nazione #
US - Stati Uniti d'America 419
IT - Italia 98
SG - Singapore 69
CN - Cina 49
DE - Germania 36
FI - Finlandia 36
HK - Hong Kong 27
EE - Estonia 22
PL - Polonia 22
IE - Irlanda 20
RU - Federazione Russa 16
TR - Turchia 15
GB - Regno Unito 13
ID - Indonesia 13
VN - Vietnam 13
IN - India 7
CZ - Repubblica Ceca 6
SE - Svezia 6
LY - Libia 5
BE - Belgio 4
FR - Francia 3
CH - Svizzera 2
UA - Ucraina 2
AU - Australia 1
BR - Brasile 1
CA - Canada 1
MA - Marocco 1
NL - Olanda 1
NZ - Nuova Zelanda 1
PH - Filippine 1
Totale 910
Città #
Chandler 89
Singapore 61
Helsinki 33
Hong Kong 27
New York 27
Ashburn 26
Milan 25
Fairfield 24
Princeton 24
Tallinn 22
Warsaw 22
Istanbul 15
Dublin 14
Jakarta 13
Brescia 12
Dong Ket 12
Rome 12
Shanghai 12
Houston 9
Menlo Park 9
Seattle 9
Wilmington 9
Boardman 8
Cambridge 8
Pune 7
Ann Arbor 6
Brno 6
London 6
Los Angeles 6
Moscow 6
Munich 6
San Diego 5
Woodbridge 5
Beijing 4
Des Moines 4
Benghazi 3
Brussels 3
Jacksonville 3
Kilburn 3
Lappeenranta 3
Parma 3
Romola 3
Bagheria 2
Brooklyn 2
Dalmine 2
Fort Worth 2
Lugano 2
Mountain View 2
Nuvolento 2
Ospitaletto 2
Rho 2
Romainville 2
Santa Clara 2
Tripoli 2
West Jordan 2
Asciano 1
Boydton 1
Calcinate 1
Catania 1
Cleveland 1
Corigliano Calabro 1
Dallas 1
Falkenstein 1
Frankfurt am Main 1
Guangzhou 1
Gunzenhausen 1
Hangzhou 1
Leawood 1
Manila 1
Mantova 1
Melbourne 1
Monmouth Junction 1
Nanchang 1
Nashville 1
Prineville 1
Redwood City 1
Reston 1
Somma Lombardo 1
St Petersburg 1
Stockholm 1
Tongling 1
Toronto 1
Torre Boldone 1
Trieste 1
Vaiano Cremasco 1
Washington 1
Weifang 1
Xi'an 1
Zhengzhou 1
Zhoukou 1
Totale 665
Nome #
Clinical and histological prognostic factors of recurrent and/or metastatic salivary gland adenoid cystic carcinoma 144
Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial 73
High Prevalence and Early Occurrence of Skeletal Complications in EGFR Mutated NSCLC Patients With Bone Metastases 70
Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinoma 68
Changes in eating habits and food preferences in breast cancer patients undergoing adjuvant chemotherapy 62
Rate of venous thromboembolism and atrial fibrillation in a real-world case series of advanced cancer patients: the CaTEV Study 61
Gene expression profiling of olfactory neuroblastoma helps identify prognostic pathways and define potentially therapeutic targets 59
A European survey on the practice of nutritional interventions in head–neck cancer patients undergoing curative treatment with radio(chemo)therapy 56
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic 52
Outcome of patients with intrathyroidal thymic carcinoma: a pooled analysis 49
Clinical and Histological Prognostic Factors of Recurrence and Malignant Transformation in a Large Series of Oral Potentially Malignant Disorders 45
Not all hematopoietic growth factors are created equal: Should we gain information for their use with immunotherapy? 44
Functional profiles of curatively treated adenoid cystic carcinoma unveil prognostic features and potentially targetable pathways 37
Cytotoxic effects of targeted agent alone or with chemotherapy in the treatment of adenoid cystic carcinoma: a preclinical study 35
Comparison of different treatments for HPV+ oropharyngeal carcinoma: a network meta-analysis 24
Evaluation of DNA methylation levels of SEPT9 and SHOX2 in plasma of patients with head and neck squamous cell carcinoma using droplet digital PCR 21
Droplet digital PCR Development to quantify the DNA methylation levels of SEPT9 and SHOX2 in plasma from patients with Head and Neck Squamous Cell Carcinoma 18
Is precision medicine the solution to improve organ preservation in laryngeal/hypopharyngeal cancer? A position paper by the Preserve Research Group 16
Revisiting the concept of neoadjuvant and induction therapy in head and neck cancer with the advent of immunotherapy 5
Totale 939
Categoria #
all - tutte 7.941
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.941


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202199 0 0 0 0 7 24 16 9 8 13 1 21
2021/2022165 16 13 9 28 11 10 2 8 9 15 10 34
2022/2023215 21 17 7 21 21 35 1 32 39 0 10 11
2023/2024213 10 7 22 19 9 42 12 16 24 10 5 37
2024/2025247 5 9 21 128 34 50 0 0 0 0 0 0
Totale 939